We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$72.4B
AUM Growth
+$3.34B
Cap. Flow
+$3.15B
Cap. Flow %
4.35%
Top 10 Hldgs %
24.2%
Holding
3,853
New
175
Increased
1,612
Reduced
1,555
Closed
162

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Financials 13.44%
3 Consumer Discretionary 11.14%
4 Healthcare 9.82%
5 Communication Services 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNI icon
3101
Nelnet
NNI
$4.48B
$7.28K ﹤0.01%
68
+17
+33% +$1.88K
AMPH icon
3102
Amphastar Pharmaceuticals
AMPH
$869M
$7.28K ﹤0.01%
196
-2,818
-93% -$129K
ARKO icon
3103
ARKO Corp
ARKO
$495M
$7.28K ﹤0.01%
+1,104
New +$7.6K
SCHH icon
3104
Schwab US REIT ETF
SCHH
$11.1B
$7.22K ﹤0.01%
343
+311
+972% +$6.95K
ARI
3105
Apollo Commercial Real Estate
ARI
$880M
$7.13K ﹤0.01%
823
-126
-13% -$1.13K
BKE icon
3106
Buckle
BKE
$2.37B
$7.06K ﹤0.01%
139
+69
+99% +$3.26K
MLR icon
3107
Miller Industries
MLR
$620M
$7.06K ﹤0.01%
108
-6
-5% -$408
GDX icon
3108
VanEck Gold Miners ETF
GDX
$27.5B
$7.05K ﹤0.01%
208
+97
+87% +$3.72K
FHTX icon
3109
Foghorn Therapeutics
FHTX
$391M
$6.97K ﹤0.01%
1,477
FRPH icon
3110
FRP Holdings
FRPH
$425M
$6.95K ﹤0.01%
227
+185
+440% +$5.66K
RVNC
3111
DELISTED
Revance Therapeutics, Inc.
RVNC
$6.92K ﹤0.01%
2,278
+2,080
+1,051% +$9.06K
OABI icon
3112
OmniAb
OABI
$491M
$6.88K ﹤0.01%
1,942
-1,974
-50% -$7.81K
PRCH icon
3113
Porch Group
PRCH
$1.79B
$6.87K ﹤0.01%
1,396
+546
+64% +$1.75K
TTEC icon
3114
TTEC Holdings
TTEC
$84.2M
$6.87K ﹤0.01%
1,376
ACRS icon
3115
Aclaris Therapeutics
ACRS
$871M
$6.86K ﹤0.01%
2,765
VHI icon
3116
Valhi
VHI
$463M
$6.83K ﹤0.01%
292
MGX icon
3117
Metagenomi Therapeutics
MGX
$45.6M
$6.83K ﹤0.01%
+1,892
New +$4.57K
RWT
3118
Redwood Trust
RWT
$588M
$6.79K ﹤0.01%
1,040
+87
+9% +$626
CATX icon
3119
Perspective Therapeutics
CATX
$363M
$6.7K ﹤0.01%
+2,101
New +$17.2K
INNV icon
3120
InnovAge Holding
INNV
$1.39B
$6.66K ﹤0.01%
1,694
-1,945
-53% -$10.1K
EEM icon
3121
iShares MSCI Emerging Markets ETF
EEM
$29.9B
$6.43K ﹤0.01%
154
+3
+2% +$133
CMP icon
3122
Compass Minerals
CMP
$1.13B
$6.4K ﹤0.01%
569
+344
+153% +$4.49K
CLOV icon
3123
Clover Health Investments
CLOV
$2.33B
$6.39K ﹤0.01%
+2,028
New +$7.25K
TNGX icon
3124
Tango Therapeutics
TNGX
$4.29B
$6.39K ﹤0.01%
2,067
+1,998
+2,896% +$9.28K
QTTB icon
3125
Q32 Bio
QTTB
$459M
$6.38K ﹤0.01%
1,856
+1,782
+2,408% +$56.3K

Similar funds

Russell Investments Group's Q4 2024 Portfolio in Review

As of Q4 2024, Russell Investments Group held 3,853 positions worth $72.4B, up 4.8% from $69.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Russell Investments Group deployed $3.15B of net new capital in Q4 2024, opening 175 new positions and adding to 1,612 existing holdings. Its largest new stake was Ares Management Corp 6.75% Series B Preferred Stock: 2,440,950 shares worth $2.69M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apollo Global Management Series A, an estimated $110M trimmed.

  • Russell Investments Group's largest Q4 2024 buy was Ares Management Corp 6.75% Series B Preferred Stock: 2,440,950 shares worth $2.69M.
  • Russell Investments Group added most to NVIDIA in Q4 2024, an estimated $402M increase.
  • Russell Investments Group's biggest Q4 2024 reduction was Apollo Global Management Series A, cutting an estimated $110M.
  • Russell Investments Group fully exited Primo Water Corporation in Q4 2024, selling an estimated $23M.
  • Russell Investments Group's ten largest holdings make up 24% of its $72.4B portfolio in Q4 2024.
  • Russell Investments Group opened 175 new positions and closed 162 in Q4 2024.
  • Russell Investments Group's portfolio value rose 4.8% quarter-over-quarter to $72.4B.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.